Experimental and computational assessment of the synergistic pharmacodynamic drug–drug interactions of a triple combination therapy in refractory HER2-positive breast cancer cells
Crossref DOI link: https://doi.org/10.1007/s10928-021-09795-4
Published Online: 2021-11-13
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vaidya, Tanaya R.
Ait-Oudhia, Sihem https://orcid.org/0000-0001-8152-3150
Text and Data Mining valid from 2021-11-13
Version of Record valid from 2021-11-13
Article History
Received: 22 March 2021
Accepted: 25 October 2021
First Online: 13 November 2021
Declarations
:
: The authors declare that there is no conflict of interest.